Meningococcal Vaccines Market Growth by Top Companies, Trends by Types and Application, Forecast to 2030
As per the research conducted by Market
Research Future (MRFR), Meningococcal Vaccines Market is projected to be worth USD 5.91 billion
by 2030, registering a CAGR of 7.29% during the forecast period (2022 - 2030),
The market was valued USD 3.12 billion in 2021. The growing
adoption of vaccination to eliminate bacterial meningitis is expected to
increase the demand for immunization therapies, which can augment the global
market in the assessment period. The growing initiatives by the government and
various authorities to counter the increasing prevalence of meningitis is
likely to offer efficient methods of immunization, which is predicted to
strengthen the industry. Furthermore, the surging funds for R&D are
projected to combat the increasing cases of meningococcal infection that is
likely to offer lucrative opportunities to vaccine manufacturing companies,
which can boost the trade.
On the other hand, stringent government
regulations for the approval of the new vaccines are likely to hamper the
market in the coming period. However, effective meningococcal vaccination
programs and the rising healthcare expenses can counter the impeding cause that
can boost the market growth during the forecast period.
Market Segmentation
The segmental analysis of the global market for
meningococcal vaccines is done by end-user and treatment type.
·
The end-user segments of the global market for
meningococcal vaccines are research & academic institutes, hospitals &
clinics, and others.
·
The treatment-type segments of the global
market for meningococcal vaccines are polysaccharides, meningococcal conjugate
vaccine, and subcapsular vaccine.
Regional Analysis
On the basis of region, the global market for
meningococcal vaccines is segmented into North America, Europe, Asia-Pacific,
and the Rest of the World (RoW).
The global market is anticipated to be
dominated by North America during the forecast period due to the growing
support from the government of various regions. High investments in R&D are
predicted to be another significant cause that can strengthen the regional
market during the forecast period. Among all, the US is projected to make the
most significant contribution in developing vaccines owing to the increasing
incidence of meningococcal diseases.
Europe is anticipated to acquire a significant
market value during the forecast period owing to the increasing research in the
concerned field. Furthermore, the growing favorable initiatives taken by the
government of various countries of the region are recognized to be another
salient cause that can develop the regional market in the coming period.
APAC is expected to grow at a significant rate
during the review period owing to the increasing incidence of meningococcal
diseases. Therefore, there has been a rise in the production of the vaccine.
The growing pediatric population and the rising initiatives taken by the
government of various countries to combat the diseases are projected to augment
the regional market during the review period.
MEA is expected to acquire a small market share
during the forecast period owing to high prices of the vaccine and limited
availability. The MEA countries have expressed interest in introducing a
multivalent and conjugate vaccine into the National Immunization Program
Schedule but have failed to do so owing to the prevailing economic crisis among
the countries.
Industry News
·
November 2020
A renowned
French pharma company, Sanofi, has received approval from the European
Commission for its Meningococcal (MenACWY) vaccine MenQuadfi. The EC has given
conformity for immunizing the individuals from the age of 12 months and older.
Key Players
The Global market for Medical Terminology Software Market Players are Serum Institute of India
Ltd., Pfizer Inc., Baxter International, Novartis Pharmaceuticals Canada Inc,
JN-International Medical Corporation, Sanofi S.A., Biomed Pvt. Ltd., and
GlaxoSmithKline, among others.
Related Report-
https://uppervote.com/read-blog/43388
https://wo.lyoncat.com/read-blog/13001
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment